Long-term monitoring for nanomedicine implants and drugs

被引：49
作者：
Kendall, Michaela [1 ]
Lynch, Iseult [2 ]
机构：
[1] Univ Birmingham, Sch Met & Mat, Edgbaston B15 2TT, England
[2] Univ Birmingham, Sch Geog Earth & Environm Sci, Edgbaston B15 2TT, England
来源：
NATURE NANOTECHNOLOGY | 2016年 / 11卷 / 03期
关键词：
HEALTH; NANOPARTICLES; NANOMATERIALS; CARE; NANOTECHNOLOGY; FUTURE; CANCER; RISK; LUNG;
D O I：
10.1038/nnano.2015.341
中图分类号：
TB3 [工程材料学];
学科分类号：
0805 ; 080502 ;
摘要：
Increasing globalization means that traditional occupational epidemiological approaches may no longer apply, suggesting a need for an alternative model to assess the long-term impact of nanomaterial exposure on health.
引用
收藏
页码：206 / +
页数：5
相关论文
共 37 条
[1]   Biological assessment of self-assembled polymeric micelles for pulmonary administration of insulin [J].
Andrade, Fernanda ;
das Neves, Jose ;
Gener, Petra ;
Schwartz, Simo, Jr. ;
Ferreira, Domingos ;
Oliva, Mireia ;
Sarmento, Bruno .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2015, 11 (07) :1621-1631
[2]  
[Anonymous], 2012, BIOMATERIAL SMARKET
[3]  
Armand L., 2016, NANOTOXICOLOGY, V19, P1
[4]  
BCC Research, 2015, NAN MED APPL GLOB MA
[5]  
Bhabra G, 2009, NAT NANOTECHNOL, V4, P876, DOI [10.1038/NNANO.2009.313, 10.1038/nnano.2009.313]
[6]   Nanomaterials and regulation of cosmetics [J].
Bowman, Diana M. ;
van Calster, Geert ;
Friedrichs, Steffi .
NATURE NANOTECHNOLOGY, 2010, 5 (02) :92-92
[7]   DNA damaging bystander signalling from stem cells, cancer cells and fibroblasts after Cr(VI) exposure and its dependence on telomerase [J].
Cogan, Nicola ;
Baird, Duncan M. ;
Phillips, Ryan ;
Crompton, Lucy A. ;
Caldwell, Maeve A. ;
Rubio, Miguel A. ;
Newson, Roger ;
Lyng, Fiona ;
Case, C. Patrick .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2010, 683 (1-2) :1-8
[8]   Nanotoxicity: challenging the myth of nano-specific toxicity [J].
Donaldson, Ken ;
Poland, Craig A. .
CURRENT OPINION IN BIOTECHNOLOGY, 2013, 24 (04) :724-734
[9]  
European Commission and ETP Nanomedicine, 2009, ROADM NAN
[10]  
Food and Drug Administration (FDA), 2014, FDA2011D0489
1234